newsfilter
← Latest News
GlobeNewswire·

Nabriva Announces Availability of XENLETA® (lefamulin) in a 10-Count Oral Pack

DUBLIN, Ireland and FORT WASHINGTON, Pa., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infect